PubRank

Suet-Feung Chin

Author PubWeight™ 128.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012 20.47
2 Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013 13.22
3 The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012 11.91
4 The landscape of cancer genes and mutational processes in breast cancer. Nature 2012 11.24
5 Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013 7.42
6 MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007 6.41
7 Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012 5.84
8 EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 2003 4.33
9 Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 2008 3.49
10 Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci Transl Med 2012 2.55
11 Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep 2013 2.37
12 The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 2013 2.22
13 ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med 2011 2.07
14 A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 2005 2.05
15 Human and mouse oligonucleotide-based array CGH. Nucleic Acids Res 2005 2.03
16 Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. Genome Res 2012 1.95
17 Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics 2012 1.74
18 Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas. J Pathol 2010 1.68
19 The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics 2009 1.55
20 p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc Natl Acad Sci U S A 2004 1.53
21 FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003 1.50
22 Regulation of p53 tetramerization and nuclear export by ARC. Proc Natl Acad Sci U S A 2007 1.41
23 Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009 1.39
24 Genome-driven integrated classification of breast cancer validated in over 7,500 samples. Genome Biol 2014 1.38
25 Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol 2004 1.37
26 ESR1 gene amplification in breast cancer: a common phenomenon? Nat Genet 2008 1.33
27 Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J Pathol 2005 1.19
28 Master regulators of FGFR2 signalling and breast cancer risk. Nat Commun 2013 1.12
29 A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene. Cancer Res 2004 1.07
30 PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes. Breast Cancer Res 2008 1.04
31 High-resolution array CGH clarifies events occurring on 8p in carcinogenesis. BMC Cancer 2008 0.98
32 Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event. Genes Chromosomes Cancer 2007 0.96
33 TOX3 mutations in breast cancer. PLoS One 2013 0.93
34 Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer. Carcinogenesis 2005 0.93
35 High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53. Clin Cancer Res 2008 0.93
36 ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML. Exp Cell Res 2006 0.92
37 Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer. Cancer Lett 2009 0.91
38 Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Res 2012 0.88
39 Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Cancer Res 2006 0.87
40 Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes. BMC Genomics 2012 0.83
41 Calling sample mix-ups in cancer population studies. PLoS One 2012 0.83
42 DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells. Am J Physiol Cell Physiol 2002 0.82
43 Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat Commun 2016 0.79
44 Cell cycle checkpoint-guarded routes to catenation-induced chromosomal instability. SEB Exp Biol Ser 2008 0.75